Alpha Tau Medical (DRTS) Profit After Tax (2021 - 2026)

Alpha Tau Medical (DRTS) has 6 years of Profit After Tax data on file, last reported at $22.9 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax rose 163.94% year-over-year to $22.9 million; the trailing twelve-month figure through Mar 2026 stood at $56.9 million (up 75.22% YoY), and the FY2025 full-year result was $42.6 million, up 34.26% from the prior year.
• Profit After Tax improved to $22.9 million in Q1 2026, from $12.1 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $25.7 million in Q1 2022 to a low of $2.0 million in Q2 2022.
• A 5-year average of $9.4 million and a median of $8.2 million in 2023 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax plunged 71.37% in 2022 and jumped 334.87% in 2023, its largest moves.
• Tracing DRTS's Profit After Tax over 5 years: stood at $3.4 million in 2022, then surged by 116.87% to $7.4 million in 2023, then advanced by 28.66% to $9.5 million in 2024, then grew by 28.07% to $12.1 million in 2025, then surged by 89.02% to $22.9 million in 2026.
• Business Quant data shows DRTS's Profit After Tax at $22.9 million in Q1 2026, $12.1 million in Q4 2025, and $11.7 million in Q3 2025.